Partnership
Quantum Surgical x NeuWave Medical
Quantum Surgical acquired NeuWave Medical, whose microwave ablation technology is used in 70% of top US cancer centers. Both operate as subsidiaries of newly created Precision IO Group, led by Kurt Azarbarzin. The combination pairs Epione's robotic platform with NeuWave's ablation technology.
investment · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/quantum-surgical-x-neuwave-medical.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/quantum-surgical-x-neuwave-medical
- Revision history: /partnerships/quantum-surgical-x-neuwave-medical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
09c99524-f129-420e-b01d-dc4bd4176df0- Type
- investment
- Status
- Activeoperating
- Announced
- 2026-02-246 months ago
- Start
- 2026-02-246 months ago
- Active for
- 6 months
Who’s involved
French medical robotics company developing the [Epione](/models/epione) robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former [Medtech SA](/companies/medtech-sa) engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.
Off-registry parties
- NeuWave Medical · other
- Precision IO Group · other
Related partnerships
Recent partnerships of the same kind
- mizuho-financial-group x Partners GroupMizuho Financial Group + Partners Groupinvestment—operating
- investment—operating
- investment—operating
- investment—operating
- investment—operating
- investment—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.